Applied Molecular Transport (AMT) is a privately held venture-backed, clinical-stage biopharmaceutical company that is applying its proprietary bioengineering technology platforms to create transformative oral biological therapies for patients with severe autoimmune, inflammatory, liver and metabolic diseases. Learn More

 

Privileged Access to GI Immunology and Convergent Pathways

Learn More

Changing the Paradigm for Biologics
 

Learn More

News:

Oct 
10, 
2019

Applied Molecular Transport Appoints Veteran Biopharmaceutical Executive, Liz Bhatt, to Role as Chief Business and Strategy Officer | Learn More

Events:

No events scheduled at this time.